|
Parenteral Manual |
Tpn/lipid Y-Site Compatibility
|
|
|
|
DRUG NAME
|
PN
|
LIPID
|
COMMENTS
|
Acyclovir
|
I
|
I
|
Visual precipitate forms
|
Albumin
|
C
|
I
|
|
Amikacin
|
C
|
I
|
Causes oiling out of fat emulsion
|
Aminophylline
|
C,I
|
C,I
|
Caution with high concentration of Ca/Phos
|
Amiodarone
|
--
|
--
|
|
Amphotericin B
|
I
|
I
|
Formation of fine yellow particles
|
Ampicillin
|
I
|
I
|
|
Atracurium
|
C
|
--
|
|
|
|
|
|
Carboplatin
|
C
|
C
|
|
Cefazolin
|
C
|
C
|
|
Cefotaxime
|
C
|
C
|
|
Ceftazidime
|
C
|
C
|
|
Ceftriaxone
|
C
|
C
|
|
Cefuroxime
|
C
|
C
|
|
Chlorpromazine
|
C
|
C
|
TPN must not contain ranitidine
|
Ciprofloxacin
|
C
|
C
|
|
Clindamycin
|
C
|
C
|
|
Cloxacillin
|
C
|
I
|
|
Clotrimoxizole
|
I
|
--
|
Precipiate forms
|
Cyclosporine
|
I
|
I
|
|
Cytarabine
|
C
|
C
|
|
|
|
|
|
Dexamethasone
|
C
|
C
|
|
Digoxin
|
C
|
C
|
|
Diphenhydramine
|
C
|
C
|
|
Dobutamine
|
C
|
C
|
|
Dopamine
|
C
|
I
|
|
Doxycycline
|
C
|
I
|
|
|
|
|
|
Enalaprilat
|
C
|
C
|
|
Epinephrine
|
C
|
--
|
|
Erythromycin
|
C
|
C
|
|
|
|
|
|
Fentanyl
|
C
|
C
|
|
Filgrstim (G-CSF)
|
I
|
I
|
|
Fluconazole
|
C
|
C
|
|
Fluorouracil
|
C
|
C
|
|
Folic acid
|
C
|
C
|
|
Furosemide
|
C
|
C
|
|
|
|
|
|
Gancyclovir
|
I
|
I
|
Precipitate forms
|
Gentamicin
|
C
|
C
|
|
Granisetron
|
C
|
C
|
|
|
|
|
|
Heparin
|
C
|
I
|
|
Hydralazine
|
--
|
--
|
|
Hydrocortisone Na succinate
|
C
|
C
|
|
Hydromorphone
|
C
|
I
|
|
Hydroxyzine
|
C
|
C
|
|
|
|
|
|
Ifosfamide
|
C
|
C
|
|
Imipenem-cilastatin
|
C
|
C
|
|
Insulin
|
C
|
C
|
TPN must not contain ranitidine
|
Isoproterenol
|
C
|
C
|
|
|
|
|
|
Lidocaine
|
C
|
C
|
|
Lorazepam
|
C
|
I
|
|
|
|
|
|
Magnesium sulfate
|
C
|
C
|
|
Mannitol
|
C
|
C
|
|
Meperidine
|
C
|
C
|
|
Meropenum
|
C
|
C
|
|
Methylprenisolone Na succinate
|
C
|
C
|
|
Metoclopramide
|
C
|
C
|
|
Metronidazole
|
C
|
C
|
|
Midazolam
|
I
|
I
|
Precipitate forms
|
Milrinone
|
C
|
--
|
|
Mitoxantrone
|
I
|
I
|
|
Morphine
|
C
|
C
|
If morphine < 1 mg/mL
|
|
|
|
|
Nitroglycerin
|
C
|
C
|
|
Nitroprusside
|
I
|
I
|
|
Norepinephrine
|
C
|
C
|
|
|
|
|
|
Octreotide
|
C
|
C
|
|
Ondansetron
|
C
|
I
|
|
|
|
|
|
Penicillin G sodium
|
C
|
C
|
|
Phenobarbitol
|
C
|
I
|
PN must not contain ranitidine
|
Phenytoin
|
I
|
I
|
Immediate precipitate
|
Phytonadione
|
C
|
C
|
|
Piperacillin
|
C
|
C
|
|
Potassium chloride
|
C
|
C
|
|
Potassium phosphate
|
I
|
I
|
Dependant on concentration. Contact pharmacy
|
Prochlorperazine
|
C
|
C
|
|
|
|
|
|
Ranitidine
|
C
|
C
|
|
|
|
|
|
Sodium bicarbonate
|
I
|
I
|
Incompatible with many electrolytes. Precipitate forms
|
|
|
|
|
Tacrolimus
|
C
|
C
|
|
Tazocin
|
C
|
C
|
|
Thiamine
|
C
|
C
|
|
Ticarcillin
|
C
|
C
|
|
Tobramycin
|
C
|
C
|
|
|
|
|
|
Vancomycin
|
C
|
C
|
|
Legend: C = Compatible; I = Incompatible; -- = Data Unclear
For drugs not listed or any other compatibility questions, please call Pharmacy
|
For drugs not listed or any other compatibility questions, please call Pharmacy
Note: in the parenteral manual monographs, compatibility with parenteral nutrition is indicated as TPN, amino acids/dextrose and/or lipids
TPN: refers to amino acids, dextrose and fat emulsion.
- If a drug is stated compatible in TPN, it is compatible with all 3 components
- If a drug is only compatible with certain components, it is stated as such: fat emulsion or amino acids/dextrose
Please be advised that the on-line CHEOnet version of this manual is the most up to date version. All directors responsible for the area need to ensure that the most up to date information is printed and placed in the manual.
The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.
CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.
Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.